Pain News and Research

Latest Pain News and Research

New screening method for cervical cancer holds promise

A method of screening women in Ghana for early signs of cervical cancer and providing preventive treatment at the same visit appears to be safe, acceptable to women and feasible, according to a study by a researcher at the Stanford University School of Medicine.

2 Apr 2007

Fragmented sleep increases spontaneous pain in women

Sleep continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous pain in women

2 Apr 2007

Coronary procedure adds no benefit over 'optimal medical therapy' alone

Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.

1 Apr 2007

Novel anti-oxidant and anti-inflammatory agent reduces coronary events

Heart attacks are caused by a build-up and instability of plaque in the coronary arteries, which is often a result of chronic inflammation of the blood vessel walls.

31 Mar 2007

Arthritis pain processed in parts of brain concerned with emotions and fear

Researchers at The University of Manchester have discovered that arthritis pain, unlike that induced as part of an experiment, is processed in the parts of the brain concerned with emotions and fear.

From The University of Manchester 30 Mar 2007

FDA announces marketing halt for GI drug, Zelnorm

The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.

30 Mar 2007

Exercise in old age prevents onset of arthritis symptoms

Women in their 70s who keep active could be dodging painful arthritis symptoms, according to research published in Arthritis Research and Therapy.

30 Mar 2007

Angioplasty doesn't outweigh medicine in study

In what some leading cardiologists are calling a "blockbuster" study, new research could alter the approach to treating patients who have cardiovascular disease but may not be at immediate risk of heart attack or stroke.

30 Mar 2007

Role of emotions in how patients feel arthritis pain

How does the brain process the experience of pain? Thanks to advances in neuroimaging, we now know the answer lies in a network of brain structures called the pain matrix.

30 Mar 2007

Study on arthritis-attributable work limitation

Arthritis, a leading cause of disability among US adults, affects 46 million people. Arthritis-attributable work limitation (AAWL) can have substantial social and economic impacts including absenteeism, reduced productivity, work loss and lower income.

29 Mar 2007

World moves closer to eradicating ancient worm disease

A neglected tropical disease that has afflicted people since ancient times has moved a step closer towards eradication. In early March, twelve more countries were declared Guinea Worm Free by the International Commission for the Certification of Dracunculiasis (Guinea Worm Disease) Eradication.

27 Mar 2007

Medications plus lifestyle changes work as well as angioplasty to reduce deaths in stable heart-disease patients

Coronary revascularization with stenting or balloon angioplasty combined with optimal medical therapy is no more effective in preventing a heart attack, other major cardiovascular events or death in patients with stable heart disease, than optimal medical therapy alone, results of a new study conducted in 50 hospitals in the U.S. and Canada has shown.

27 Mar 2007

FDA warning on mineral water containing arsenic

The Food and Drug Administration (FDA) is re-issuing its warning to consumers not to drink "Jermuk" brand mineral water due to the risk of exposure to arsenic, a toxic substance and a known cause of cancer in humans.

25 Mar 2007

Surgical treatment comparison for spinal disease

Patients with serious degenerative spinal disease, a painful condition in which the normal function of spinal vertebrae breaks down, are presented with what can be a confusing array of surgical options.

21 Mar 2007

Tiny injected gel particles to help chronic lower back pain

Scientists at The University of Manchester believe injections of tiny sponge-like particles could provide an alternative to major surgery in the treatment of chronic lower back pain.

From The University of Manchester 21 Mar 2007

Promising new pain-killing drug

A potential new pain-killing drug developed by medical scientists at the University of Leicester and Ferrara in Italy is to be discussed at a public lecture on 20th March.

19 Mar 2007

FDA approves Soliris (eculizumab), first treatment for paroxysmal nocturnal hemoglobinuria

The U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death.

19 Mar 2007

Penwest confirms action on Oxymorphone patent application

Penwest Pharmaceuticals has confirmed that the U.S. Patent and Trademark Office (PTO) has posted on its website an indication that a final rejection of Penwest's patent application claiming the sustained release formulations of Oxymorphone will be mailed.

15 Mar 2007

Crocodiles provide clues to new pain treatments for humans

Sydney University researchers have identified how crocodiles and other reptiles detect temperature - shedding new light on their adaptation to environmental changes and pointing to new pain treatments for humans.

14 Mar 2007

Talk therapy works for panic disorder

Psychoanalytic therapies have been in professional use for over a century, but a new study from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first to show that a classic psychoanalytic talk therapy is efficacious in treating panic disorder.

14 Mar 2007